Literature DB >> 17645640

Role of reactive metabolites of oxygen and nitrogen in partial liver transplantation: lessons learned from reduced-size liver ischaemia and reperfusion injury.

Hidejiro Urakami1, Yuta Abe, Matthew B Grisham.   

Abstract

1. Hepatic resection with concomitant periods of ischaemia and reperfusion (I/R) is required to perform reduced-size liver (RSL) transplantation procedures, such as living donor or split liver transplantation. Although a great deal of progress has been made using these types of surgical procedures, a significant number of patients develop tissue injury from these procedures, ultimately resulting in graft failure. 2. Because of this, there is a real need to understand the different mechanisms responsible for the tissue injury induced by I/R of RSL transplantation (RSL + I/R), with the ultimate goal to develop new and improved therapeutic agents that may limit the tissue damage incurred during RSL transplantation. 3. The present paper reviews the recent studies that have been performed examining the role of reactive metabolites of oxygen and nitrogen in a mouse model of RSL + I/R. In addition, we present data demonstrating how the pathophysiological mechanisms identified in this model compare with those observed in a model of RSL transplantation in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645640     DOI: 10.1111/j.1440-1681.2007.04640.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  16 in total

1.  Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death.

Authors:  Yanjun Shi; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

2.  Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Béla Horváth; Sándor Bátkai; Ogyi Park; Galin Tanchian; Rachel Y Gao; Vivek Patel; David A Wink; Lucas Liaudet; György Haskó; Raphael Mechoulam; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-03-11       Impact factor: 7.376

Review 3.  Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature.

Authors:  Dronacharya Routh; Sudeep Naidu; Sanjay Sharma; Priya Ranjan; Rajesh Godara
Journal:  J Clin Exp Hepatol       Date:  2013-12-05

4.  Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; Venkat K Ramshesh; Tom P Theruvath; Kenneth D Chavin; Rick G Schnellmann; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2012-05-15       Impact factor: 7.376

5.  Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts.

Authors:  Songqing He; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Transplantation       Date:  2010-02-15       Impact factor: 4.939

6.  Nrf2 activation protects the liver from ischemia/reperfusion injury in mice.

Authors:  Kazuhiro Kudoh; Hiroshi Uchinami; Masato Yoshioka; Ekihiro Seki; Yuzo Yamamoto
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

7.  Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.

Authors:  Laura Llacuna; Montserrat Marí; Josep M Lluis; Carmen García-Ruiz; José C Fernández-Checa; Albert Morales
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

8.  Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia-reperfusion injury.

Authors:  Betul Unal; Filiz Ozcan; Hazal Tuzcu; Ebru Kırac; Gulsum O Elpek; Mutay Aslan
Journal:  Redox Rep       Date:  2016-03-24       Impact factor: 4.412

9.  Exogenous hydrogen sulfide protects against hepatic ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress and cell apoptosis.

Authors:  Liang Chen; Keqiang Ma; Haining Fan; Xiaolong Wang; Tiansheng Cao
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

Review 10.  NOX enzymes as novel targets for drug development.

Authors:  J David Lambeth; Karl-Heinz Krause; Robert A Clark
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.